Chen Xiyao, Hu Guangyu, Wang Yuanyuan, Li Congye, Zhang Fuyang
Department of Geriatrics, Xijing Hospital, Air Force Medical University, Xi'an, China.
Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Front Cell Dev Biol. 2021 Jan 28;8:630421. doi: 10.3389/fcell.2020.630421. eCollection 2020.
Cardiac energy homeostasis is strictly controlled by the mitochondrial complex-mediated respiration. In the heart, mitochondrial complex I is highly susceptible to functional and structural destroy after ischemia/reperfusion (I/R), thereby contributing to myocardial energy insufficiency and cardiomyocyte death. Fas-activated serine/threonine kinase (FASTK) is recently recognized as a key modulator of mitochondrial gene expression and respiration. However, the role of FASTK in cardiac I/R process is undetermined. Here, we show that FASTK expression was down-regulated in the post-I/R heart. The reactive oxygen species scavenger N-acetyl-L-cysteine reversed I/R-induced FASTK down-regulation. Genetic deletion of FASTK exacerbated I/R-induced cardiac dysfunction, enlarged myocardial infarct size, and increased cardiomyocyte apoptosis. Compared with the wild type control, the FASTK deficient heart exhibited a lower mRNA expression of NADH dehydrogenase subunit-6 (MTND6, a mitochondrial gene encoding a subunit of complex I) and was more vulnerable to I/R-associated complex I inactivation. Replenishment of FASTK expression via adenovirus-mediated gene delivery restored mitochondrial complex I activity and ameliorated cardiomyocyte death induced by I/R, whereas these beneficial effects were blocked by the co-treatment with rotenone, a specific complex I inhibitor. experiments further confirmed that cardiac overexpression of FASTK ameliorated I/R-related MTND6 down-regulation and mitochondrial complex I inactivation, thereby protecting the heart against I/R injury. Collectively, these data for the first time identify that the down-regulation of FASTK is a direct culprit behind the loss of mitochondrial complex I functional integrity and cardiac injury induced by I/R process. Targeting FASTK might be a promising and effective strategy for MI/R intervention.
心脏能量稳态由线粒体复合物介导的呼吸严格控制。在心脏中,线粒体复合物I在缺血/再灌注(I/R)后极易受到功能和结构破坏,从而导致心肌能量不足和心肌细胞死亡。Fas激活的丝氨酸/苏氨酸激酶(FASTK)最近被认为是线粒体基因表达和呼吸的关键调节因子。然而,FASTK在心脏I/R过程中的作用尚不确定。在此,我们表明FASTK表达在I/R后的心脏中下调。活性氧清除剂N-乙酰-L-半胱氨酸可逆转I/R诱导的FASTK下调。FASTK基因缺失加剧了I/R诱导的心脏功能障碍、扩大了心肌梗死面积并增加了心肌细胞凋亡。与野生型对照相比,FASTK缺陷的心脏NADH脱氢酶亚基6(MTND6,一种编码复合物I亚基的线粒体基因)的mRNA表达较低,并且更容易受到I/R相关的复合物I失活的影响。通过腺病毒介导的基因传递补充FASTK表达可恢复线粒体复合物I活性并改善I/R诱导的心肌细胞死亡,而这些有益作用被特异性复合物I抑制剂鱼藤酮的共同处理所阻断。实验进一步证实,心脏中FASTK的过表达改善了I/R相关的MTND6下调和线粒体复合物I失活,从而保护心脏免受I/R损伤。总的来说,这些数据首次确定FASTK下调是I/R过程中线粒体复合物I功能完整性丧失和心脏损伤背后的直接罪魁祸首。靶向FASTK可能是心肌梗死/再灌注干预的一种有前景且有效的策略。